Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.316 EUR | +0.15% | +13.06% | -53.99% |
05-24 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
05-24 | Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy | CI |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG28/05/2024 | 29/05/2024 | 30/05/2024 | 31/05/2024 | |
---|---|---|---|---|
Last | 1.27 € | 1.312 € | 1.314 € | 1.316 € |
Change | -.--% | +3.31% | +0.15% | +0.15% |
Performance
1 day | +0.15% | ||
1 week | +13.06% | ||
1 month | -1.05% | ||
3 months | -44.24% | ||
6 months | -56.42% | ||
Current year | -53.99% | ||
1 year | +115.74% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+0.15% | +13.06% | -53.99% | +115.74% | 220M | ||
+1.06% | -0.49% | +11.60% | +32.46% | 106B | ||
+1.87% | +3.76% | -4.68% | -6.96% | 24.28B | ||
+1.04% | +0.89% | -0.82% | -7.69% | 21.96B | ||
+0.31% | +0.55% | -10.12% | -28.84% | 18.16B | ||
+0.41% | -1.50% | -42.12% | -37.93% | 16.37B | ||
-3.50% | -2.53% | -17.47% | -34.53% | 15.56B | ||
-0.91% | -2.86% | +2.77% | +46.67% | 13.63B | ||
+4.28% | +5.12% | +34.58% | +3.69% | 12.27B | ||
-3.39% | +150.23% | +77.64% | +181.73% | 8.87B | ||
-1.71% | +3.60% | +7.26% | +47.97% | 7.75B | ||
+0.09% | +2.20% | +11.89% | +38.52% | 7.65B | ||
+0.25% | -1.43% | -3.92% | +22.05% | 7.42B | ||
-7.66% | -3.38% | -33.51% | -36.87% | 7.29B | ||
+0.78% | -0.78% | +234.55% | +179.44% | 6.87B | ||
+4.40% | +5.47% | -9.57% | +13.05% | 6.32B | ||
Average | -0.16% | +10.64% | +12.76% | +33.03% | ||
Weighted average by Cap. | +0.41% | +5.04% | +8.96% | +20.00% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
- Stock Market
- Equities
- RENB Stock
- 2Q5 Stock
- Quotes Renovaro Inc.